Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses

Stock Information for Quantum Biopharma Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Quantum Biopharma Ltd.

Medicus Pharma Ltd. Announces Voting Results Following the Annual and Special Meeting of Shareholders
Medicus Pharma Ltd. to Present at BTIG Virtual Biotech Conference 2025
Medicus Pharma Ltd. Announces Submission of Type C Meeting Request to the Food and Drug Administration (FDA)
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
Medicus Pharma Ltd. to Present at 2025 Bio International Convention
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.